This inventor holds 1 USPTO granted patent. Top assignee: Samyang Genex Co.. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Jin-Eon So: Innovator in Protein Purification Techniques
Introduction
Jin-Eon So, an accomplished inventor based in Taejeon, South Korea, has made significant contributions to the field of biochemistry through his innovative research. With a specialization in methods for protein purification, So has secured recognition within his industry.
Latest Patents
So holds a patent for a unique method of removing endotoxin from samples containing basic proteins. His invention outlines an efficient process that involves adding a surfactant to the solution obtained from recombinant microorganisms, mixing the resultant mixture, and utilizing a cation exchange column for protein purification. This method not only enhances the quality of the basic proteins but also streamlines the purification process, making it particularly valuable in biotechnological applications.
Career Highlights
Jin-Eon So is currently employed at Samyang Genex Co., a company known for its advancements in biopharmaceuticals and biotechnology. Throughout his career, So has focused on developing techniques that improve the efficacy of protein processing and purification, contributing to the advancements in pharmaceutical research and production.
Collaborations
In his pursuit of innovation, Jin-Eon So has collaborated with notable colleagues, including Sang-Hyun Pyo and Heung-Bok Park. Their combined expertise in the field has led to fruitful research initiatives and developments that further the understanding and manipulation of biochemical processes.
Conclusion
Jin-Eon So stands out as a prominent inventor in the realm of protein purification. His patented method for endotoxin removal showcases his dedication to enhancing biotechnological processes, which ultimately contribute to more effective drug development and biopharmaceutical applications. As research continues to evolve, So's work will likely serve as a pivotal foundation for future innovations in the biotechnology sector.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile